Effect of cyclophosphamide on the rat thymus

Area of Science:

• Immunology
• Toxicology
• Cell Biology

Background:

• Cyclophosphamide (Cy) is an alkylating agent used in chemotherapy.
• Its impact on the thymus, a critical organ for T-cell development, is significant.
• Understanding Cy-induced thymic changes is crucial for managing its side effects.

Purpose of the Study:

• To investigate the morphological and functional effects of a single high dose of cyclophosphamide on the thymus.
• To characterize the cellular changes during thymic involution and regeneration.
• To assess the recovery of immune function post-cyclophosphamide treatment.

Main Methods:

• Administration of a single high dose (200 mg/kg) of cyclophosphamide to study subjects.
• Morphological examination of thymic tissue at various time points.
• Assessment of lymphocyte populations, macrophage activity, and cellular vacuolization.
• Evaluation of Fc-dependent rosette formation capacity.

Main Results:

• Cyclophosphamide induced rapid thymic involution, with cortical lymphocyte depletion and thymic inversion by day 4.
• Macrophages containing acid phosphatase granules, lipids, and residual material infiltrated the cortex.
• Epithelial and special cells showed cytoplasmic vacuolization.
• Regeneration initiated by day 4, primarily in the subcapsular region, with complete morphological recovery by day 11.
• Fc-dependent rosette formation capacity remained suppressed even on day 16.

Conclusions:

• High-dose cyclophosphamide causes severe, yet reversible, thymic damage.
• Macrophage activity and cellular changes are key features of the involution phase.
• While thymic morphology recovers, functional immune deficits may persist longer, highlighting the need for careful monitoring.